News

“We are delighted about Linda’s decision to join Arbor Vita at this time,” commented Peter S. Lu, founder, president and chief executive officer. “Linda brings to AVC an

Roche has signed a definitive agreement with innovatis, a provider of automated cell analysis solutions, pursuant to which, Roche will acquire 100% of innovatis for E15m. This acquisition

Lanxess reported a net loss of €41m for the fourth quarter of 2008, in comparison with a net profit of €5m in the year-ago period of 2007. Sales

Forma Therapeutics, a biopharmaceutical company, and the Experimental Therapeutics Centre of Singapore, have signed a collaboration agreement to leverage Forma’s transformative chemistry platform to discover novel compounds for

On March 3, SOCMA members and staff met with key EPA staff in North Carolina to discuss the chemical manufacturing area sources proposed rule. The meeting concluded with

The growth and development of nanotechnology now includes a broad range of companies engaged in the production and use of nanoscale materials. Nanotech startups and other companies associated

Nobilon, the human vaccine business unit of Schering-Plough, has initiated its first-in-human clinical development program for SCH 900795, a new intranasal live attenuated influenza vaccine for annual seasonal

Takeda Pharmaceutical Company has launched Ecard, a fixed dose combination tablet of Blopress and a low-dose diuretic for treatment of hypertension. According to Takeda, Ecard is a fixed

YM BioSciences, an oncology product development company, has enrolled the first patient into its multinational trial of nimotuzumab for the treatment of patients with non-small-cell lung cancer. This